(Press-News.org) Flu season is upon us, and existing vaccines are only ~40-60% effective at reducing the risk of serious illness. While any level of protection against influenza viruses is better than none, there remains a lot of room for improvement of future vaccines. The Precision Vaccines Program (PVP) at Boston Children’s Hospital was awarded a Vaccine Adjuvant Development Program contract (75N93023C00040) from the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) that can extend up to 5 years and $9 million, to develop a small molecule adjuvant to enhance the effectiveness of flu vaccines.
In collaboration with Inimmune, a biotech company based out of Missoula, Montana, the PVP engineered PVP-037, a novel imidazopyrimidine small molecule that activates a white blood cell receptor called Toll-like receptor 7/8 (TLR7/8) and shows promise as an immunomodulator, or a molecule that changes the body’s immune response. Building on this achievement, the team is committed to refining the adjuvant molecule and optimizing its formulation to enhance vaccine efficacy and durability. This adjuvant approach will be first applied to protein-based flu vaccines, but could be expanded to improve other platforms, such as mRNA vaccines.
“PVP is dedicated to safeguarding public health through cutting-edge research and development. This NIH funding represents a significant milestone in the quest to enhance flu vaccine efficacy, ultimately strengthening our collective ability to combat seasonal influenza,” said Ofer Levy, MD, PhD, the director of PVP.
David Dowling, PhD, a PVP faculty member who is joint principal investigator on the project stated, “Our innovative precision adjuvant discovery approach, focusing on advancing tools that best serve vulnerable populations, culminated in the invention of the PVP-037 family of adjuvants. We now look forward to the opportunity to develop this molecule as a lead adjuvant to enhance activity of influenza vaccines for all age groups. “
Led by Drs. Levy and Dowling, the project will advance the synthesis, formulation, and pre-clinical evaluation of PVP-037 small molecule in human cell culture and animal models. This comprehensive approach aims to position the molecule for an eventual clinical trial.
In addition to Inimmune, the PVP will be supported by teams at Brigham and Women’s Hospital, The Dana-Farber Cancer Institute, University of Maryland School of Medicine, and the International Vaccine Centre at the University of Saskatchewan.
“Inimmune is excited to expand our long-standing and productive collaboration with Boston Children’s Hospital towards the advancement and clinical evaluation of novel vaccine adjuvants. Inimmune will assist with the process-development and manufacturing of a novel synthetic adjuvant and formulations selected for clinical development in collaboration with Boston Children’s,” said Jay Evans, PhD, Chief Scientific and Strategy Officer at Inmmune.
The molecule that Inimmune and the PVP are creating could increase the magnitude of the body’s immune response to vaccines, enabling shots to protect against more variants and eliciting better protection for vulnerable populations, such as people with weakened immune systems. “By enhancing the effectiveness of vaccines, we can fortify the defenses of those who need it most, ensuring a safer and healthier future for all,” said Dr. Levy.
About Boston Children’s Hospital
Boston Children’s Hospital is ranked among the best children’s hospitals in the nation by U.S. News & World Report and is a pediatric teaching affiliate of Harvard Medical School. Home to the world’s largest research enterprise based at a pediatric medical center, its discoveries have benefited both children and adults since 1869. Today, 3,000 researchers and scientific staff, including 11 members of the National Academy of Sciences, 23 members of the National Academy of Medicine and 9 Howard Hughes Medical Investigators comprise Boston Children’s research community. Founded as a 20-bed hospital for children, Boston Children’s is now a 485-bed comprehensive center for pediatric and adolescent health care. For more, visit our Answers blog, and follow us on social media: @BostonChildrens, @BCH_Innovation, Facebook, YouTube and Instagram.
END
Boston Children’s Hospital receives a contract of up to $9 million from NIH to improve flu vaccines
The Precision Vaccines Program at Boston Children’s Hospital will collaborate with Inimmune to advance a next generation of small molecule vaccine adjuvants
2023-10-24
ELSE PRESS RELEASES FROM THIS DATE:
CityU joint research creates 3D-printed aluminium alloy with unprecedented fatigue resistance
2023-10-24
It is estimated that over 80% of engineering failures are due to material fatigue, so the fight against metal fatigue failures continues, as this is a key parameter for lightweight structures for all mechanical systems, such as aircraft, automobile and energy-production systems. Recently, joint research by City University of Hong Kong (CityU) and Shanghai Jiao Tong University achieved a breakthrough by creating an aluminium alloy with unprecedented fatigue resistance using advanced 3D printing techniques. ...
Certain per- and polyfluoroalkyl “forever chemicals” identified as potential risk factor for thyroid cancer
2023-10-24
Mount Sinai researchers have discovered a link between certain per- and polyfluoroalkyl substances (PFAS) and an increased risk for thyroid cancer, according to a study published in eBioMedicine today.
PFAS, also known as “forever chemicals,” are a large, complex group of synthetic chemicals that can migrate into the soil, water, and air. Due to their strong carbon-fluorine bond, these chemicals do not degrade easily in the environment. Forever chemicals been used in consumer products around the world since the 1940s, including nonstick cookware, water-repellent clothing, stain-resistant fabrics, and other products that resist grease, water, and oil.
Multiple national and international ...
UN study reveals the hidden environmental impacts of bitcoin: Carbon is not the only harmful byproduct
2023-10-24
Hamilton, Canada: The extraordinary rise in cryptocurrency prices over the previous decade has prompted huge investments in the cryptocurrency sector. Undeniably, digital currencies have won the faith of the world's top investors, ranging from large corporations and tech millionaires to criminals, money launderers, and sanction busters.
Thanks to blockchain and other technological breakthroughs, digital currencies now constitute an advanced element of the world’s modern financial ...
Study: School debate programs linked to improvements in academic achievement, graduation rates, and college enrollment
2023-10-24
Washington, October 24, 2023—Participating in policy debate programs in middle and high school is associated with improvements in English language arts (ELA) achievement and increases in the likelihood that students graduate from high school and enroll in postsecondary education, according to new research. The study was published today in Educational Evaluation and Policy Analysis, a peer-reviewed journal of the American Educational Research Association. It was conducted by Beth Schueler from the University of Virginia and Katherine Larned from Harvard University.
Video: Study co-author Beth Schueler discusses ...
Banana trees to fight wildfires
2023-10-24
Fire buffers composed of irrigated banana trees could slow and calm wildfires and generate profit for residents of fire-prone regions, according to a study. Climate change is increasing wildfire risk. Wildfires in the Western United States doubled in frequency between 1984 and 2015. At the same time, more people are living in the wildland-urban interface (WUI) than ever before, an area that often has high or extreme fire risk. Barath Raghavan and colleagues investigate the potential of banana trees to act as a multifunctional fire buffer in the WUI. Banana trees have a high water content, ideal for stopping fire. When irrigated by recycled water, they can produce ...
Study shows engineered gut bacteria can treat hypertension
2023-10-24
Scientists at The University of Toledo have proven that engineered bacteria can lower blood pressure, a finding that opens new doors in the pursuit of harnessing our body’s own microbiome to treat hypertension.
The study, published this month in the peer-reviewed journal Pharmacological Research, represents a paradigm shift, said Dr. Bina Joe, a hypertension researcher at UToledo and the paper’s senior author.
“The question we always ask is, can we exploit microbiota to help our health, for which optimal blood pressure is a cardinal sign. Until now, we have simply said ...
Light, freshwater sticks to Greenland's east coast
2023-10-24
Meltwater that runs along the east coast of Greenland, hardly enters the open ocean before reaching the western side of the island. That is one of the conclusions NIOZ PhD-candidate Elodie Duyck draws in the thesis she is defending today at Utrecht University. In the changing climate, fresh water from Greenland and the Arctic could disrupt the circulation in the Atlantic Ocean. “Understanding where, and how much, of that fresh and light water enters the Atlantic Ocean is critical to predict how the circulation may evolve under climate change”, Duyck ...
Older adults from distressed communities attend less cardiac rehab after heart procedures
2023-10-24
Older adults who live in disadvantaged communities are less likely to attend cardiac rehabilitation after common heart procedures, a Michigan Medicine-led study finds.
The study aimed to calculate how many Medicare beneficiaries attended cardiac rehabilitation, a medically supervised program exercise and education program, after coronary revascularization between mid-2016 and 2018.
Patient communities were categorized using the Distressed Community Index, which analyzes economic well-being and social determinants of health, such as educational disparities and poverty rate, of United States zip codes.
Only ...
Finding the genes that help kingfishers dive without hurting their brains
2023-10-24
If you’ve ever belly-flopped into a pool, then you know: water can be surprisingly hard if you hit it at the wrong angle. But many species of kingfishers dive headfirst into water to catch their fishy prey. In a new scientific study in the journal Communications Biology, researchers compared the DNA of 30 different kingfisher species to zero in on the genes that might help explain the birds’ diet and ability to dive without sustaining brain damage.
The type of diving that kingfishers do-- what researchers call “plunge-diving”-- is an aeronautic feat. “It’s a high-speed dive from air to water, and it’s done by very few bird species,” says ...
Two regions of the brain critical to integrating semantic information while reading, UTHealth Houston research finds
2023-10-24
Two different regions of the brain are critical to integrating semantic information while reading, which could shed more light on why people with aphasia have difficulty with semantics, according to new research from UTHealth Houston.
The study, led by first author Elliot Murphy, PhD, postdoctoral research fellow in the Vivian L. Smith Department of Neurosurgery with McGovern Medical School at UTHealth Houston, and senior author Nitin Tandon, MD, professor and chair ad interim of the department in the medical school, was published today in Nature Communications.
Language depends largely on the integration of vocabulary across multiple words ...
LAST 30 PRESS RELEASES:
Researchers illuminate inner workings of new-age soft semiconductors
University of Houston partners with Harris County to create a sustainable energy future
Looking deeper into the mirror
Friends of BrainHealth donor circle awards coveted grants to fuel innovative research
Study of infertility, health among women of Mexican heritage funded by $2.2M NIH grant
Airborne plastic chemical levels shock researchers
DOD awards $9M for snowpack and meltwater research and Arctic training program in Alaska and New England
SETI Institute awards education grant through the STRIDE program
NYU Historian Jennifer L. Morgan wins 2024 MacArthur “Genius Grant”
Research in 4 continents links outdoor air pollution to differences in children’s brains
UTA physicists explore possibility of life beyond Earth
Seeing double: Designing drugs that target “twin” cancer proteins
Fierce names Insilico Medicine as one of its Fierce 50 Honorees of 2024
Cleveland Clinic researchers build first large-scale atlas of how immune cells react to mutations during cancer immunotherapy
Pioneering quantum computer research continues in Baden-Württemberg
Discovery of orbital angular momentum monopoles enables orbital electronics with chiral materials
New mouse models offer valuable window into COVID-19 infection
Antibodies in breast milk provide protection against common GI virus
University of Cincinnati professor named MacArthur fellow
Research provides new insights into role of mechanical forces in gene expression
HSE scientists have developed a new model of electric double layer
UK ParkRun participants report improved life satisfaction six months later
‘Who’s a good boy?’ Humans use dog-specific voices for better canine comprehension
A third of Swedish cheerleaders tell of psychological abuse
Authoritarian populism has weakened democracy in Brazil - study
Climate scientists express their views on possible future climate scenarios in a new study
Anu wins first place, $20,000 in SCORE’s 60th Anniversary Pitch Competition
NSF funds project to examine social, environmental impacts of AI
New study: neuroscientists spark shelter-seeking response by reactivating memory circuit
Wendy Connors named Hertz Foundation President, succeeding Robbee Kosak
[Press-News.org] Boston Children’s Hospital receives a contract of up to $9 million from NIH to improve flu vaccinesThe Precision Vaccines Program at Boston Children’s Hospital will collaborate with Inimmune to advance a next generation of small molecule vaccine adjuvants